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Apolipoprotein A-I (ApoA-I) is the major protein component of high-
density lipoprotein (HDL), and is critical for maintenance of cholesterol
homeostasis. During reverse cholesterol transport, HDL transitions
between an array of subclasses, differing in size and composition. This pro-
cess requires ApoA-I to adapt to changes in the shape of the HDL particle,
transiting from an apolipoprotein to a myriad of HDL subclass-specific
conformations. Changes in ApoA-I structure cause alterations in HDL-
specific enzyme and receptor-binding properties, and thereby direct the
HDL particle through the reverse cholesterol transport pathway. In this
study, we used site-directed spin label spectroscopy to examine the confor-
mational details of the ApoA-I central domain on HDL. The motional
dynamics and accessibility to hydrophobic/hydrophilic relaxation agents of
ApoA-I residues 99–163 on 9.6-nm reconstituted HDL was analyzed by
EPR. In previous analyses, we examined residues 6–98 and 164–238 (of
ApoA-I’s 243 residues), and combining these findings with the current
results, we have generated a full-length map of the backbone structure of
reconstituted HDL-associated ApoA-I. Remarkably, given that the
majority of ApoA-I’s length is composed of amphipathic helices, we have
identified nonhelical residues, specifically the presence of a b-strand
(residues 149–157). The significance of these nonhelical residues is dis-
cussed, along with the other features, in the context of ApoA-I function in
contrast to recent models derived by other methods.
Introduction
Apolipoprotein A-I (ApoA-I) is the major protein
component of high-density lipoprotein (HDL) and a
key mediator of plasma cholesterol transport and
cellular cholesterol homeostasis [1]. During reverse
cholesterol transport, ApoA-I interacts with cellular
receptors/transporters such as ATP-binding cassette A1
(ABCA1), ATP-binding cassette G1 and scavenger
receptor BI, which are necessary for efficient choles-
terol and phospholipid efflux and delivery. In addition
to these, several soluble plasma factors, including leci-
thin cholesterol-acyl transferase (LCAT), cholestery-
lester transfer protein, and an array of lipoprotein
lipases, contribute to the metabolism of HDL, which
include transition between lipid-free/poor ApoA-I,
Abbreviations
ABCA1, ATP-binding cassette A1; ApoA-I, apolipoprotein A-I; CrOx, chromium oxalate; HDL, high-density lipoprotein; HX, hydrogen–
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discoidal HDL, and spherical HDL [2]. The adapta-
tion of ApoA-I’s structural organization on HDL
occurs in response to both particle geometry and com-
position, and in turn leads to changes in HDL affinity
for receptors and plasma factors. Thus, a thorough
understanding of ApoA-I’s structure and response to
changes in HDL subclass are critical for fully under-
standing HDL function and its regulation.
Determining ApoA-I’s structure has proven difficult
for both the lipid-free state and for the HDL-associ-
ated form of the protein. Much of the challenge is
attributable to ApoA-I’s flexibility and plasticity, in
addition to its propensity for self-association. To over-
come these issues, we have employed EPR spectros-
copy, which is ideal for examining proteins with a
dynamic structure and is unaffected by the target pro-
tein’s oligomerization state. We have determined the
secondary structure of the central domain of ApoA-I
on 9.6-nm reconstituted HDL (rHDL). Together with
our previous analysis of the N-terminal and C-terminal
domains of ApoA-I [3,4], the secondary structure of
the central domain (residues 99–163) provides a com-
plete map of ApoA-I’s secondary structure on 9.6-nm
rHDL particles.
Results and Discussion
Side chain mobility of residues in the central
domain of ApoA-I on 9.6-nm rHDL
Sixty-two single-Cys ApoA-I variants with substitu-
tions within residues 99–163 were covalently nitroxide
spin-labeled by the use of thiol chemistry, reconsti-
tuted on 9.6-nm rHDL, and analyzed by EPR spec-
troscopy (Fig. 1). The shapes of the spectra provide
direct information on the degree of motional freedom
of the labeled side chain (e.g. residues 103 and 106;
Fig. 1B), wherein sharp and broadened spectra indi-
cate high and low motional freedom, respectively. The
mobility parameter d1, which is the inverse of the
central line width, provides a relative measure of side
chain mobility [5], and was used here to determine
ApoA-I’s central domain secondary structure
(Fig. 1C). Mutants with Cys substitutions at resi-
dues 100, 102 and 109 were excluded from analyses,
owing to low protein solubility. Figures 1C and 2
include data from an additional 10 residues upstream
and downstream ([3] and [4], respectively) of the cen-
tral domain residues (99–163) to demonstrate that,
A
C
B
Fig. 1. EPR spectroscopy was used to determine the structure of the central domain of ApoA-I on 9.6-nm rHDL particles. (A) ApoA-I on 9.6-nm
rHDL bearing a nitroxide label (MTSL) was analyzed by EPR spectroscopy. (B) The central line width (arrows) of the resulting spectra is
representative of the labeled amino acid’s side chain mobility, where broader (D103C, top) and narrower (K106C, bottom) line widths indicate
low and high mobility, respectively. (C) The inverse spectral line width (d1) plotted as a function of residue number is used to identify
secondary structure elements. Solid and dashed black lines indicate consecutive and missing data points, respectively. A sinusoidal-shaped
periodicity of 3.6 residues per cycle indicates an a-helical structure (orange), whereas an alternating periodicity indicates a b-strand structure
(blue). Data for residues 88–173 are plotted, wherein residues 99–163 are from the current study.
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although we have defined residues 99–163 as the cen-
tral domain, this is a numerical assignment, and does
not define a conformational domain. Within this
domain, there are four regions (103–116, 118–136,
138–148, and 160–173) that show a pattern of d1 with
a periodicity indicative of a typical a-helix (3.6; see
orange sinusoidal curve in Fig. 1C). However, resi-
dues 149–159 do not follow this pattern, but instead
show an alternating periodicity indicative of b-strand
secondary structure. The exception to this is Arg151,
whose mobility (d1 = 0.37) does not conform to the
alternating pattern that one would expect for a
b-strand. Given the relatively high mobility of its
neighbors (positions 150 and 152), one would expect
d1 for position 151 to fall within the immobile range
of this series (≤ 0.25), which it does not. Interestingly,
the chromium oxalate (CrOx) accessibility of
position 151 is significantly lower than that of its
neighbors, which conforms to an alternating periodic-
ity of a b-strand. There is more than one possible
explanation for why position 151 does not show the
degree of mobility expected of a residue on a b-strand.
For instance, a stable b-strand may only transiently
exist at position 151, narrowing the EPR spectrum via
rapid backbone motions. Also, the pattern of mobility
is obscured for a span of residues of fixed secondary
structure when there are discontinuities in surface
exposure, as mobility is a function not only of the
extent of each residue’s contact with other molecules,
but also of its degree of solvent exposure. In addition
to the mobility discrepancy at position 151, the mobility
of residues 117 and 137 is ambiguous, and it is difficult
to discern by mobility alone whether these residues
reside within a contiguous helix (residues 103–148). As
with residue 151, this ambiguity is resolved by determin-
ing the pattern of residue-specific molecular accessibil-
ity/degree of solvent exposure (see below).
Solvent accessibility of the central domain of
ApoA-I on 9.6-nm rHDL
The molecular accessibility of ApoA-I central domain
residues on 9.6-nm rHDL particles was determined by
observing the relative susceptibility of nitroxide label
to the presence of hydrophilic (CrOx) or hydrophobic
(O2) paramagnetic relaxation agents. The degree of
attenuation of spectral intensity attributable to the col-
lision frequency of a diffusible relaxer and the nitrox-
ide spin label is a quantitative measure of the solvent
accessibility of the nitroxide-modified side chain. In
Fig. 2, the accessibility parameter (Π) of CrOx is plot-
ted as a function of residue. Molecular accessibility
Fig. 2. The accessibility of diffusible spin relaxers provide a measure of the hydrophobicity of the spin-labeled side chain environment. Top:
The contrast function (Φ), which is the logarithmic value of the ratio between the hydrophobic (O2) and the hydrophilic (CrOx) paramagnetic
relaxers, is a relative measure of the hydrophobicity of the local microenvironment of the labeled side chain, and is plotted as a function of
residue number. Bottom: the accessibility parameter of the hydrophilic relaxer (ΠCrOx), a measure of the relative hydrophilicity of the local
microenvironment of the labeled side chain, is plotted as a function of residue number. Larger contrast function values and lower
accessibility values of the hydrophilic relaxer indicate greater hydrophobicity. Solid and dashed black lines indicate consecutive and missing
data points, respectively. A sinusoidal-shaped periodicity of 3.6 residues per cycle indicates an a-helical structure (orange), whereas an
alternating periodicity indicates a b-strand structure (blue). Data for residues 88–173 are plotted, wherein residues 99–163 are from the
current study.
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was determined for all residues between positions 99
and 163, with the exception of residues 100, 102, 109,
and 128.
To identify the residues whose side chains are parti-
tioned into the lipid environment of the HDL particle,
the relative collision frequency of O2 was compared
with that of CrOx (polarity contrast function, Φ;
Fig. 2, upper panel). For residues in an exposed
hydrophilic location, ΠCrOx is higher in value than
ΠO2, resulting in negative Φ values. For residues in a
hydrophobic environment, ΠO2 is greater than ΠCrOx,
and Φ is more positive in value. This approach is
specifically useful for proteins that have significant
exposure to both hydrophilic and hydrophobic envi-
ronments, such as lipid-bound ApoA-I protein. The
plotted values of ΠCrOx and Φ for ApoA-I residues
(Fig. 2) show the hallmark sinusoidal pattern of sol-
vent accessibility that is indicative of an a-helical
structure, consistent with mobility analysis observa-
tions. In addition, the data support a continuous heli-
cal structure for residues 117 and 137 (Fig. 1C). As
discussed above, the apparent lack of fitting of the
mobility of residues 117 and 137 to a helical pattern is
probably explained by deviations in surface contact/
exposure (e.g. intramolecular and/or intermolecular
protein contact). The mobility of position 137 is con-
sistent with the ‘looped belt’ model, wherein resi-
dues 134–145 form a loop-like element on 9.6-nm
rHDL particles [6,7], and a majority of these residues
maintain their helical facing to the lipid environment
of the HDL particle (Fig. 3). Thus, the loop of the
‘looped belt’ model is not derived from a random coil
loop but rather from an arced helix, with hinges at
residues 133, 139, and 146 [7], consistent with the
molecular dynamics simulations of Segrest et al. [8].
The altered facing of residue 137 is consistent with a
deviation in protein–lipid contact that one would
expect near a helix hinge. The polar accessibility
parameter (ΠCrOx) and contrast function (Φ) show an
alternating pattern for residues 149–157, consistent
with a b-strand structure.
Secondary structure of ApoA-I on 9.6-nm
rHDL–EPR versus other approaches
Combined with our previous EPR analyses of the
N-terminal [3] and C-terminal [4] domains of ApoA-I,
our current analysis provides a complete description
of the secondary structure of ApoA-I on 9.6-nm
rHDL (Fig. 3). The structure has two major helical
regions, residues 50–148 and residues 158–243, that
are separated by a short stretch of amino acids (resi-
dues 149–157) that form a b-strand. There is a second
b-strand structure at residues 40–50, which neighbors
a short random coil segment (residues 35–39) that is
connected to an a-helix (residues 6–34). The average
helical percentage of ApoA-I in this structure is
~ 85%, which is similar to the helical content deter-
mined with CD spectroscopy (~ 78%) [9].
Recently, Chetty et al. [10] used hydrogen–deute-
rium exchange (HX) combined with MS analysis to
determine the solution structure of ApoA-I on rHDL.
The secondary structure distribution from their analy-
sis identified two major helical segments (residues
7–124 and 159–236) separated by a bimodal region
with two structural states (helical and random coil)
that interchange on the minute scale. Several features
of the HX model are in agreement with the EPR-based
structure. These include an extended a-helix in the
C-terminal domain and also a significant portion of
Fig. 3. Comparison of secondary structure models of ApoA-I. The secondary structure maps of ApoA-I as determined by EPR spectroscopy
(top), HX MS analysis (middle [10]) and X-ray crystallography (residues 1–184; bottom [12,13]) are shown. The position of the loop-like
element (residues 134–145) defined in the ‘looped belt’ model [7] is indicated.
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helical structure in the N-terminal and central domains
(Fig. 3). Interestingly, part of the region described as
bimodal in the HX model corresponds to a region of
the central domain that EPR analysis identifies as a
b-strand. Both methods support a nonhelical character
for this region, although they arrive at different con-
clusions with respect to whether it is an organized or
disorganized structure (random coil versus b-strand).
In contrast to this general agreement, the random coil
and b-strand structures defined by EPR in the N-ter-
minal domain (residues 35–50) are not present in the
HX model. The reason for this difference may be the
concentrations of HDL employed in the two studies,
or the difference in resolution of the methods. EPR
and HX experiments were performed at 60 lM and
5 lM ApoA-I (or 30 lM and 2.5 lM rHDL), respec-
tively. Although the effect of concentration on the dis-
coidal HDL ApoA-I structure is unknown, the
structure and oligomeric state of lipid-free ApoA-I are
concentration dependent [11]. Further studies are war-
ranted to determine whether there is a relationship
between HDL concentration and resident ApoA-I
structure, as this would have an impact on our under-
standing of the regulation of interactions between
HDL and its associated receptors/enzymes. This differ-
ential observation may also be a result of the ability of
HX to identify b-strands in proteins, as this technique
has a limited resolution at the peptide level, whereas
EPR can distinguish structural parameters at the resi-
due level. Nevertheless, despite these discrepancies,
both methods show this region to contain nonhelical
structures.
We next compared our results with the recently pub-
lished crystal structure of a fragment of ApoA-I span-
ning residues 1–184 [12]. Despite being crystallized in
the absence of lipids, several features of the crystal
structure are rHDL-like in conformation [13]. These
features include a curved elongated helical structure
with a diameter of ~ 11 nm. Interestingly, both the
short helix (residues 6–34) and a random coil/b-strand
region (residues 35–50) observed by EPR spectroscopy
in the N-terminal domain of ApoA-I on rHDL are
found in the crystal structure of the fragment (Fig. 4),
supporting our results and suggesting that the recent
crystal structure is more likely to be representative of
a lipid-bound conformation. Interestingly, the N-termi-
nal structure in lipid-free ApoA-I, as determined by
EPR spectroscopic analysis [11], is significantly altered
upon rHDL association [3].
Transition of ApoA-I structure from the apo-state
to discoidal 9.6-nm rHDL
During lipid binding and HDL maturation, ApoA-I
undergoes a series of changes in conformation [14]. In
a previous EPR analysis of lipid-free ApoA-I, we
determined that its secondary structure is divided into
shorter helical regions (< 30 residues) separated by
random coil or b-strand regions (Fig. 4) [11]. Four
b-strand segments are identified in the lipid-free solu-
tion structure. Of these, one b-strand is also present in
ApoA-I on 9.6-nm rHDL (residues 149/150 to 157/
158). The fact that residues 149–157 maintain a con-
served b-strand structure in both lipid-free and lipid-
bound ApoA-I (Fig. 4) suggests a specific role of this
region in the biogenesis and maturation of HDL. This
is underscored by the number of variants of ApoA-I
with amino acid substitutions in, or near, this region
that have reduced LCAT activation and/or low levels of
plasma ApoA-I/HDL. These include the R151C Paris
[15], L159R Finnish [16] and L159P Zavalla [17] vari-
ants. In addition, the central residue in this b-strand,
Arg153, is completely conserved in mammals, birds, and
amphibians [18], and is important for LCAT binding to
Fig. 4. Schematic representation of secondary structure distribution of ApoA-I on 9.6-nm rHDL as compared with lipid-free ApoA-I.
Secondary structure depiction from this study (residues 99–163), Lagerstedt et al. [3] (residues 1–98 [3]) and Oda et al. [4] (residues 163–
243) of lipid-bound 9.6-nm rHDL particles (top) and lipid-free ApoA-I (bottom [11]). The position of the loop-like element (residues 134–145)
defined in the ‘looped belt’ model [7] is indicated.
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HDL [19], which further emphasizes the importance of
this residue and its proximal residues in HDL matura-
tion. The importance of this region in the interaction
with ABCA1, ATP-binding cassette G1, scavenger
receptor BI and cholesterylester transfer protein is not
clear. However, although a conformational rearrange-
ment of the central region occurs during ABCA1-
mediated lipid binding, recent data instead indicate that
the N-terminal and C-terminal regions of ApoA-I
interact directly with ABCA1 [20,21] suggesting a minor
role of the identified ApoA-I b-strand in the ABCA1
interaction.
In addition to regions that transition from b-strand
to a-helix upon lipid binding, one region that is pri-
marily helical in lipid-free ApoA-I (residues 40–50)
adopts a b-strand structure on 9.6-nm rHDL. Interest-
ingly, the solvent exposure of this region is signifi-
cantly altered during the expansion of smaller
discoidal HDL particles (diameter of 7.8 nm) to
9.6-nm HDL particles [3], but the b-strand is retained
as a consistent element in the rHDL particle. This sug-
gests that, unlike the other ApoA-I b-strands that
transition to a-helix during HDL formation [11], resi-
dues 40–50 do not play a role in the stabilization of
the lipid-free protein, but rather may be important in
the stability and/or maturation of HDL. The rationale
underlying this conclusion is that transient b-strand
elements in lipid-free ApoA-I serve as pseudolipids,
providing a nucleation center for the hydrophobic face
of ApoA-I’s amphipathic helices, thereby stabilizing
the lipid-free ApoA-I helical bundle [11]. Upon lipid
binding, these b-strands transition to a-helices, elimi-
nating the amphipathic helices’ hydrophobic nucleus,
and driving the helices to partition into the lipid envi-
ronment of the forming HDL particle.
Conclusion
The current analysis provides a complete and detailed
description of the secondary structure of ApoA-I on
9.6-nm rHDL. From this study, we conclude that the
majority of the protein on 9.6-nm rHDL adopts a heli-
cal structure (residues 6–34, 50–148, and 158–243),
with the exception of residues 40–50 and 149–158,
which form b-strands. The helical content in this struc-
ture is ~ 85% and the b-strand content is ~ 9%, both
of which are similar to the values determined with CD
spectroscopy (70–78% a-helical [9,20,21] and 10–11%
b-strand [22,23]. Several of the structural features iden-
tified by EPR are present in a recently proposed struc-
ture based on HX analysis [10]. However, there are
significant differences in the structural assignments of
the two methods. On the basis of our EPR analyses,
EPR provides better resolution in defining helical
regions, and is able to discern b-strands from random
coils. The crystal structure of truncated lipid-free
ApoA-I (residues 1–184), although a lipid-free peptide,
might be more representative of HDL-associated
ApoA-I [13], which is analogous to the observations
made of the crystal structure of an N-terminal trunca-
tion of ApoA-I (Δ1–43) [24]. It is intriguing that the
crystal model of residues 1–184 is similar to our EPR-
derived rHDL model, most notably in that both depict
residues 40–50 as nonhelical. Whereas the b-strand at
residues 40–50 may play a key role in the adaptation
of ApoA-I to changes in discoidal HDL size [3], we
speculate that the b-strand at residues 149–158 is
important for establishing the proper alignment of
ApoA-I monomers in the lipid-free apo-state, which
establishes the alignment of ApoA-I monomers on dis-
coidal particles [7] that are subsequently stabilized by
salt bridging [25]. This hypothesis is further supported
by a molecular dynamics simulation that positions res-
idues 149–158 proximal to their counterparts on a
paired ApoA-I during HDL formation [8]. Further-
more, after discoidal HDL formation, the b-strand at
residues 149–158 may be critical for the interaction
with LCAT by presenting a unique protein-binding
element, in which b-strands are commonly utilized.
We will employ this structural model of ApoA-I on
9.6-nm HDL as the basis for future experimental work
to investigate the relationship between ApoA-I struc-
tural properties and HDL function.
Experimental procedures
Materials
Thio-specific nitroxide spin label (1-oxyl-2,2,5,5-tetrameth-
ylpyrroline-3-methyl)-methanethiosulfonate) was purchased
from Toronto Research Chemicals (Toronto). 1-Palmitoyl-
2-oleoyl-sn-glycero-phosphocholine (POPC) and cholesterol
were purchased from Avanti Polar Lipids (Alabaster, AL,
USA).
Production of recombinant and spin-labeled
ApoA-I
Sixty-two single Cys substitutions of ApoA-I (P99C–
L163C) were previously created by either primer-directed
PCR mutagenesis or the megaprimer PCR method [11].
The proteins were expressed, purified and reacted with a
methanethiosulfonate spin label (MTSL), as previously
described [4]. In brief, 8 mg of protein was sequentially
incubated with 100 lM Tris-(2-carboxyethyl)phosphine and
300 lM MTSL on an Ni2+ -chelated HiTrap column (GE
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Healthcare) under denaturing conditions (3 M guanidine-
HCl), extensively washed with NaCl/Pi (20 mM phosphate,
500 mM NaCl), and eluted with imidazole. Protein purity
(> 95%) was confirmed by SDS/PAGE.
HDL reconstitution
rHDLs were prepared with the deoxycholate method
[26,27]. Dried POPC and free cholesterol were resuspended
in NaCl/Tris (8.2 mM Tris/HCl, 150 mM NaCl, 0.1 mM
EDTA), pH 8.0, with 19 mM sodium deoxycholate. The
mixture was vortexed and incubated at 37 °C until it was
clarified. Spin-labeled ApoA-I was added to the mixture,
and incubated for 1 h at 37 °C. Deoxycholate was removed
by extensive dialysis against NaCl/Tris (pH 8). Protein/lipid
molar ratios (ApoA-I/free cholesterol/POPC) were
1 : 4 : 80 for 9.6-nm rHDL. Residual lipid-free protein was
removed from the preparation by KBr density gradient ul-
tracentrifugation at 50 000 g for 3 h in a Beckman Optima
TLA 100.4 rotor. Homogeneous rHDL was isolated by size
exclusion chromatography as previously described [28]. The
size and purity of lipidated discoidal complexes was con-
firmed by nondenaturing gradient gel electrophoresis, as
previously described [29].
EPR analysis
A JEOL X-band spectrometer fitted with a loop-gap res-
onator [30] was used for EPR measurements. Aliquots
(5 lL) of purified rHDL (60 lM spin-labeled protein)
were loaded into quartz capillaries, and spectra were col-
lected at room temperature (20–22 °C) from a single
2-min scan with 100 G sweep width at a microwave
power of 2 mW and a modulation amplitude optimized
to the natural line width of the individual spectrum (0.5–
1.5 G). For integration of spin counts, samples were
structurally dispersed by addition of SDS to a final con-
centration of 2% (w/v), and the resulting EPR spectrum
was double-integrated for total spin intensity. The molec-
ular accessibility of spin-labeled side chains to the para-
magnetic relaxation agents CrOx and O2 was determined
by the use of successive power saturation scans [31,32].
These measurements provide a normalized value for the
collision frequency (Π) of the diffusible agent. The Φ
parameter describes the polarity of the local environment,
and is calculated from the log of the ratio between polar
(ΠCrOx) and apolar (ΠO2) relaxers, and is especially use-
ful in analyses of protein partitioning in lipid assemblies
[33].
Molecular modeling
CHIMERA (UCSF) [34] was used to compare the crystal
structure of the 1–184 fragment (Protein Data Bank 3R2P)
[12] and a model of lipid-bound ApoA-I on 9.6-nm rHDL
[3].
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